Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.

CONCLUSION: While research has generally supported Kava in non-clinical populations (potentially for more 'situational' anxiety as a short-term anxiolytic), this particular extract was not effective for diagnosed generalised anxiety disorder.
PMID: 31813230 [PubMed - as supplied by publisher]

Source: The Australian and New Zealand Journal of Psychiatry - December 7, 2019 Category: Psychiatry Authors: Sarris J, Byrne GJ, Bousman CA, Cribb L, Savage KM, Holmes O, Murphy J, Macdonald P, Short A, Nazareth S, Jennings E, Thomas S, Ogden E, Chamoli S, Scholey A, Stough C Tags: Aust N Z J Psychiatry Source Type: research